Project Grant R01MD020675
- The National Heart, Lung, and Blood Institute awarded the University of Pennsylvania $685,212 on August 15, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to develop policy-relevant evidence on the scope and effects of prior authorization (PA) for cardiovascular care. The project quantifies patient exposure to PA for cardiovascular services from 2016 through 2024, identifying which patient groups experience PA barriers and measuring how PA affects service use, care...
- The National Heart, Lung, and Blood Institute awarded Research Institute At Nationwide Children's Hospital $1,326,945 on September 10, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837) to develop a translatable molecular imaging paradigm for comprehensive assessment of peripheral artery disease (PAD). The recipient will characterize stages of peripheral atherosclerosis using dual-phase PET/CT imaging with fluorine-18 sodium fluoride (18F-NAF) to quantify both regional muscle...
- The National Institute of Neurological Disorders and Stroke awarded Yale University $4.17 million on August 25, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop a biopsychosocial model for peripheral artery disease pain management that integrates vascular interventions with psychological and behavioral assessment. The project develops novel MRI protocols to evaluate blood flow, muscle and nerve microstructure, and metabolism in patients with peripheral artery...
- The National Institute on Aging awarded the University of Pennsylvania $811,172 on September 1, 2026, under the Aging Research program (CFDA 93.866) to conduct a five-year prospective observational study testing whether economic scarcity affects medication adherence and uptake of preventive services among older adults with chronic disease. The research enrolls 400 adults aged 50 years or older who receive Supplemental Nutrition Assistance Program (SNAP) benefits and are prescribed once-daily...
- The National Institute for Minority Health and Health Disparities awarded Drexel University $780,647 on July 7, 2026, under the Minority Health and Health Disparities Research program (CFDA 93.307) to develop and test GANAS, a 10-week men's health intervention targeting low-income men. GANAS delivers weekly workshops, skill-building, and digital engagement through Facebook groups facilitated by trained peer mentors, addressing chronic stress, sleep quality, social connectedness, coping...
- The National Heart, Lung, and Blood Institute awarded Thomas Jefferson University $629,068 on July 15, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct research into the role of isoaspartyl-induced protein damage in diabetic angiogenesis and peripheral artery disease. The research investigates how isoaspartyl residue accumulation—a form of spontaneous protein damage—contributes to vascular dysfunction and impaired angiogenesis in diabetes. The work focuses on...
- The National Heart, Lung, and Blood Institute awarded the University of Florida $688,383 under the Cardiovascular Diseases Research program (CFDA 93.837) on September 1, 2026, to support preclinical and translational research on mitochondrial efficiency in peripheral artery disease. The project, titled "Enhancing OXPHOS Efficiency to Promote Muscle Function and Regeneration in Peripheral Artery Disease," will develop strategies to optimize leg muscle oxidative metabolism in PAD...
- The National Institute for Minority Health and Health Disparities awarded the University of Southern California $1,362,414 on July 28, 2026, under the Minority Health and Health Disparities Research program (CFDA 93.307) to evaluate how Medicaid coverage changes affect diabetic foot ulcer (DFU) outcomes in safety-net populations. The research examines how insurance coverage and covered podiatry services influence outpatient foot care utilization, emergency department visits, and DFU outcomes...
- Federal Grant Award Summary The Pennsylvania State University received a $1.58M Project Grant from the National Institute on Minority Health and Health Disparities (NIMHD) under the Minority Health and Health Disparities Research program (CFDA 93.307), awarded September 19, 2025, with a completion date of June 30, 2027. This research initiative evaluates the integration of care between pediatric primary care providers and Women, Infants, and Children (WIC) program nutritionists to prevent...
- Duke University's Office of Research Administration is conducting a mixed-methods research study funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This $242,250 R03 Project Grant, awarded August 12, 2025, with a completion date of July 31, 2027, expands preliminary work conducted in West Virginia to identify geographic amputation "hot spots" and risk...
The National Institute for Minority Health and Health Disparities awarded The Trustees of the University of Pennsylvania $755,882 on August 18, 2026, under the Minority Health and Health Disparities Research program (CFDA 93.307) to conduct a randomized controlled trial testing virtual disease management interventions for peripheral artery disease in low-socioeconomic-status communities. The project tests two separate components of a comprehensive virtual disease management platform designed for patients newly diagnosed with PAD through community screening. The intervention incorporates PAD-specific education, encourages doctor-patient discussions regarding pharmacologic management, promotes physical activity, and connects patients who smoke with smoking cessation resources. The platform builds on the University of Pennsylvania's Way to Health software, which processes patient-generated data and automates incentive and feedback delivery. Previous research using this platform demonstrated that interventions incorporating gamification and education increased physical activity and quality of life compared with control among PAD patients. Work is performed in Pennsylvania and runs through January 31, 2031. The award is structured as a Project Grant, the standard assistance type for investigator-initiated NIH research.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $755.9k | 8/20/26 |